Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Pla2g15 | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Pla2g15 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in increased expression of PLA2G15 mRNA | CTD | PMID:22206623 | Pla2g15 | Rat | 17alpha-ethynylestradiol | affects expression | ISO | Pla2g15 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of PLA2G15 mRNA | CTD | PMID:17555576 | Pla2g15 | Rat | 17beta-estradiol | decreases expression | ISO | Pla2g15 (Mus musculus) | 6480464 | Estradiol results in decreased expression of PLA2G15 mRNA | CTD | PMID:39298647 | Pla2g15 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of PLA2G15 mRNA | CTD | PMID:22298810 | Pla2g15 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PLA2G15 mRNA | CTD | PMID:34747641 | Pla2g15 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Pla2g15 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of PLA2G15 mRNA | CTD | PMID:21570461 | Pla2g15 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PLA2G15 mRNA | CTD | PMID:21215274 | Pla2g15 | Rat | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of PLA2G15 mRNA | CTD | PMID:21346803 | Pla2g15 | Rat | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Pla2g15 (Mus musculus) | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PLA2G15 mRNA | CTD | PMID:20188158|PMID:26251327 | Pla2g15 | Rat | 3-chloropropane-1,2-diol | increases expression | EXP | | 6480464 | alpha-Chlorohydrin results in increased expression of PLA2G15 mRNA | CTD | PMID:28522335 | Pla2g15 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Pla2g15 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of PLA2G15 mRNA | CTD | PMID:39298647 | Pla2g15 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of PLA2G15 mRNA | CTD | PMID:30047161 | Pla2g15 | Rat | amiodarone | affects expression | ISO | PLA2G15 (Homo sapiens) | 6480464 | Amiodarone affects the expression of PLA2G15 mRNA | CTD | PMID:29248575 | Pla2g15 | Rat | benzo[a]pyrene | increases expression | ISO | Pla2g15 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of PLA2G15 mRNA | CTD | PMID:22228805 | Pla2g15 | Rat | beta-hexachlorocyclohexane | decreases expression | ISO | Pla2g15 (Mus musculus) | 6480464 | beta-hexachlorocyclohexane results in decreased expression of PLA2G15 mRNA | CTD | PMID:25270620 | Pla2g15 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | PLA2G15 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of PLA2G15 protein | CTD | PMID:31163220 | Pla2g15 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of PLA2G15 mRNA | CTD | PMID:25181051|PMID:30816183|PMID:32528016 | Pla2g15 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of PLA2G15 mRNA | CTD | PMID:32145629 | Pla2g15 | Rat | bisphenol A | decreases methylation | ISO | Pla2g15 (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of PLA2G15 promoter | CTD | PMID:27312807 | Pla2g15 | Rat | Butylbenzyl phthalate | increases methylation | ISO | Pla2g15 (Mus musculus) | 6480464 | butylbenzyl phthalate results in increased methylation of PLA2G15 intron | CTD | PMID:28392331 | Pla2g15 | Rat | C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of PLA2G15 mRNA | CTD | PMID:19167457 | Pla2g15 | Rat | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLA2G15 more ... | CTD | PMID:39012411 | Pla2g15 | Rat | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLA2G15 more ... | CTD | PMID:39012411 | Pla2g15 | Rat | capsaicin | decreases expression | EXP | | 6480464 | Capsaicin results in decreased expression of PLA2G15 mRNA | CTD | PMID:20349343 | Pla2g15 | Rat | carbon nanotube | increases expression | ISO | Pla2g15 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in increased expression of PLA2G15 mRNA | CTD | PMID:25554681 | Pla2g15 | Rat | chlorpyrifos | increases expression | ISO | Pla2g15 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of PLA2G15 mRNA | CTD | PMID:37019170 | Pla2g15 | Rat | cisplatin | increases expression | ISO | Pla2g15 (Mus musculus) | 6480464 | Cisplatin results in increased expression of PLA2G15 mRNA | CTD | PMID:15464296 | Pla2g15 | Rat | cisplatin | increases expression | ISO | PLA2G15 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of PLA2G15 mRNA | CTD | PMID:27594783 | Pla2g15 | Rat | Dibutyl phosphate | affects expression | ISO | PLA2G15 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of PLA2G15 mRNA | CTD | PMID:37042841 | Pla2g15 | Rat | doxorubicin | increases expression | ISO | PLA2G15 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of PLA2G15 mRNA | CTD | PMID:29803840 | Pla2g15 | Rat | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of PLA2G15 mRNA | CTD | PMID:29391264 | Pla2g15 | Rat | ethyl methanesulfonate | increases expression | ISO | PLA2G15 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of PLA2G15 mRNA | CTD | PMID:23649840 | Pla2g15 | Rat | fenthion | decreases expression | ISO | Pla2g15 (Mus musculus) | 6480464 | Fenthion results in decreased expression of PLA2G15 mRNA | CTD | PMID:34813904 | Pla2g15 | Rat | fentin chloride | increases expression | EXP | | 6480464 | triphenyltin chloride results in increased expression of PLA2G15 mRNA | CTD | PMID:37156404 | Pla2g15 | Rat | finasteride | increases expression | EXP | | 6480464 | Finasteride results in increased expression of PLA2G15 mRNA | CTD | PMID:24136188 | Pla2g15 | Rat | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of PLA2G15 mRNA | CTD | PMID:24136188 | Pla2g15 | Rat | GW 7647 | decreases expression | EXP | | 6480464 | GW 7647 results in decreased expression of PLA2G15 mRNA | CTD | PMID:31628012 | Pla2g15 | Rat | lead(0) | affects expression | ISO | PLA2G15 (Homo sapiens) | 6480464 | Lead affects the expression of PLA2G15 mRNA | CTD | PMID:28903495 | Pla2g15 | Rat | lipopolysaccharide | decreases expression | ISO | PLA2G15 (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of PLA2G15 mRNA | CTD | PMID:35811015 | Pla2g15 | Rat | lipopolysaccharide | multiple interactions | ISO | PLA2G15 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PLA2G15 mRNA | CTD | PMID:35811015 | Pla2g15 | Rat | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of PLA2G15 mRNA | CTD | PMID:30047161 | Pla2g15 | Rat | methyl methanesulfonate | increases expression | ISO | PLA2G15 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of PLA2G15 mRNA | CTD | PMID:23649840 | Pla2g15 | Rat | monosodium L-glutamate | increases expression | ISO | Pla2g15 (Mus musculus) | 6480464 | Sodium Glutamate results in increased expression of PLA2G15 mRNA | CTD | PMID:22078008 | Pla2g15 | Rat | okadaic acid | increases expression | ISO | PLA2G15 (Homo sapiens) | 6480464 | Okadaic Acid results in increased expression of PLA2G15 mRNA | CTD | PMID:38832940 | Pla2g15 | Rat | paracetamol | increases expression | ISO | PLA2G15 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of PLA2G15 mRNA | CTD | PMID:22230336|PMID:29067470 | Pla2g15 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of PLA2G15 mRNA | CTD | PMID:33387578 | Pla2g15 | Rat | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of PLA2G15 mRNA | CTD | PMID:32680482 | Pla2g15 | Rat | pirinixic acid | multiple interactions | ISO | PLA2G15 (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... | CTD | PMID:19710929 | Pla2g15 | Rat | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of PLA2G15 mRNA | CTD | PMID:28374803 | Pla2g15 | Rat | rotenone | increases expression | ISO | PLA2G15 (Homo sapiens) | 6480464 | Rotenone results in increased expression of PLA2G15 protein | CTD | PMID:39603559 | Pla2g15 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | PLA2G15 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PLA2G15 mRNA | CTD | PMID:35811015 | Pla2g15 | Rat | silicon dioxide | decreases expression | ISO | Pla2g15 (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of PLA2G15 mRNA | CTD | PMID:19073995 | Pla2g15 | Rat | silicon dioxide | increases expression | ISO | PLA2G15 (Homo sapiens) | 6480464 | Silicon Dioxide results in increased expression of PLA2G15 mRNA | CTD | PMID:25351596 | Pla2g15 | Rat | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide results in increased expression of PLA2G15 mRNA | CTD | PMID:32721576 | Pla2g15 | Rat | sodium arsenate | increases expression | ISO | Pla2g15 (Mus musculus) | 6480464 | sodium arsenate results in increased expression of PLA2G15 mRNA | CTD | PMID:39847705 | Pla2g15 | Rat | sodium benzoate | increases expression | ISO | PLA2G15 (Homo sapiens) | 6480464 | Sodium Benzoate results in increased expression of PLA2G15 protein | CTD | PMID:30154464 | Pla2g15 | Rat | sulfadimethoxine | decreases expression | EXP | | 6480464 | Sulfadimethoxine results in decreased expression of PLA2G15 mRNA | CTD | PMID:30047161 | Pla2g15 | Rat | tamoxifen | affects expression | ISO | Pla2g15 (Mus musculus) | 6480464 | Tamoxifen affects the expression of PLA2G15 mRNA | CTD | PMID:17555576 | Pla2g15 | Rat | testosterone | decreases expression | ISO | Pla2g15 (Mus musculus) | 6480464 | Testosterone results in decreased expression of PLA2G15 mRNA | CTD | PMID:21669218 | Pla2g15 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of PLA2G15 mRNA | CTD | PMID:23411599 | Pla2g15 | Rat | titanium dioxide | decreases methylation | ISO | Pla2g15 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of PLA2G15 promoter | CTD | PMID:35295148 | Pla2g15 | Rat | urethane | increases expression | ISO | PLA2G15 (Homo sapiens) | 6480464 | Urethane results in increased expression of PLA2G15 mRNA | CTD | PMID:28818685 | Pla2g15 | Rat | valproic acid | increases methylation | ISO | PLA2G15 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of PLA2G15 gene | CTD | PMID:29154799 | Pla2g15 | Rat | valproic acid | increases expression | ISO | PLA2G15 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of PLA2G15 mRNA | CTD | PMID:23179753|PMID:27188386|PMID:29154799 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















